Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Synthesis of Emergent Biotechnologies into Future CPG
Jeffrey I. Mechanick
, Angelo Carpi
,
Mark L. Urken
, Donald A. Bergman
,
Rhoda H. Cobin
Icahn School of Medicine at Mount Sinai
Medicine
Medicine - Cardiology
Medicine - Endocrinology, Diabetes and Bone Disease
Metabolism and Lipids Program
Mount Sinai Institute for Systems Biomedicine
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Synthesis of Emergent Biotechnologies into Future CPG'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Practice Guidelines
100%
Biotechnology
100%
Targeted Therapy
40%
Knowledge Gaps
40%
Guideline Recommendations
40%
Clinical Setting
20%
Molecular Imaging
20%
Risky Driving
20%
Prevention Strategies
20%
Genetic Studies
20%
Imaging Techniques
20%
Surgical Procedures
20%
Risk Stratification
20%
Molecular Pathogenesis
20%
Bioinformatics
20%
Current Clinical Practice
20%
Secondary Prevention
20%
Geographic Region
20%
Optimal Management
20%
Clinical Investigation
20%
Resource Availability
20%
Primary Prevention
20%
Radiopharmaceuticals
20%
Multimodality Approach
20%
Molecular Medicine
20%
Single Approach
20%
Guideline Methodology
20%
Risk-based Design
20%
Early Adoption
20%
Image-guided Radiotherapy
20%
Medicine and Dentistry
Targeted Therapy
100%
Knowledge Gap
100%
Imaging Technique
50%
Surgical Technique
50%
Risk Stratification
50%
Patient Referral
50%
Secondary Prevention
50%
Molecular Pathology
50%
Primary Prevention
50%
Image-Guided Radiation Therapy
50%
Radiopharmaceutical
50%
Genetics
50%
Neuroscience
Imaging Technique
100%
Radiopharmaceutical
100%
Radiation Therapy
100%
Genetics
100%
Pharmacology, Toxicology and Pharmaceutical Science
Molecular Pathology
100%